5-(苯并噻吩-2-基)-1H-吲唑 | 885272-48-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 中文名称: 5-(苯并噻吩-2-基)-1H-吲唑
• 英文名称: 5-(Benzothiophen-2-YL)-1H-indazole
• 英文别名: 5-(1-benzothiophen-2-yl)-1H-indazole
• CAS: 885272-48-0
• 化学式: C₁₅H₁₀N₂S
• 分子量: 250.32
• InChiKey: ZVLIUJUEWWITKD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  56.9
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Novel 2-Heteroaryl Substituted Benzothiophenes and Benzofuranes 709
  申请人：Arzel Erwan

  公开号：US20080221149A1

  公开（公告）日：2008-09-11

  The present invention relates to novel 2-heteroaryl substituted benzothiophene and benzofuran derivatives, precursors thereof, and therapeutic uses of such compounds, having the structural formula (Ia) below: and to their pharmaceutically acceptable salt, compositions and methods of use. Furthermore, the invention relates to novel 2-heteroaryl substituted benzothiophene and benzofuran derivatives that are suitable for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease as well as measureing clinical efficacy of Alzheimer's disease therapeutic agents.

  本发明涉及新型2-杂环芳基取代苯并噻吩和苯并呋喃衍生物，其前体以及这些化合物的治疗用途，具有如下结构式(Ia)： 以及它们的药用盐、组合物和使用方法。此外，本发明涉及适用于在活体患者中成像淀粉样沉积物的新型2-杂环芳基取代苯并噻吩和苯并呋喃衍生物，它们的组合物、使用方法以及制备这类化合物的过程。更具体地，本发明涉及一种在体内成像脑部淀粉样沉积物的方法，以允许在死前诊断阿尔茨海默病，并测量阿尔茨海默病治疗药物的临床疗效。
• Substituted bicyclic compounds as bromodomain inhibitors
  申请人：ZENITH EPIGENETICS LTD.

  公开号：US10166215B2

  公开（公告）日：2019-01-01

  The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

  本发明涉及取代的双环化合物，这些化合物可通过与溴结构域结合来抑制 BET 蛋白的功能；本发明还涉及包含这些化合物的药物组合物，以及这些化合物和组合物在治疗中的应用。
• NOVEL SUBSTITUTED BICYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS
  申请人：ZENITH EPIGENETICS LTD.

  公开号：US20170216257A1

  公开（公告）日：2017-08-03

  The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.
• US7772256B2
  申请人：——

  公开号：US7772256B2

  公开（公告）日：2010-08-10
• US9662311B2
  申请人：——

  公开号：US9662311B2

  公开（公告）日：2017-05-30